Oncotelic Therapeutics, Inc. Repayments of Debt
Oncotelic Therapeutics, Inc. (OTLC) reported Repayments of Debt of $500.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-18.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2022-11-18
- Oncotelic Therapeutics, Inc. repayments of debt for the quarter ending 2022-09-30 was $0.00.
- Oncotelic Therapeutics, Inc. repayments of debt for the quarter ending 2022-06-30 was $500.00K, a 900.00% increase year-over-year.
- Oncotelic Therapeutics, Inc. repayments of debt for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- Oncotelic Therapeutics, Inc. repayments of debt for the quarter ending 2021-12-31 was $0.00.
- Oncotelic Therapeutics, Inc. repayments of debt for fiscal 2021 was $100.00K.
| Period end | Repayments of Debt 3 month | Repayments of Debt 6 month | Repayments of Debt 9 month | Repayments of Debt 12 month |
|---|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-18 | $500.00K derived: sum of 2 quarters · filed 2022-11-18 | $500.00K 10-Q · filed 2022-11-18 | $500.00K derived: sum of 4 quarters · filed 2022-11-18 |
| 2022-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22 | $500.00K 10-Q · filed 2022-08-22 | $500.00K derived: sum of 3 quarters · filed 2022-08-22 | $500.00K derived: sum of 4 quarters · filed 2022-11-18 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-23 | $0.00 derived: sum of 2 quarters · filed 2022-05-23 | $0.00 derived: sum of 3 quarters · filed 2022-11-18 | $50.00K derived: sum of 4 quarters · filed 2022-11-18 |
| 2021-12-31 | $0.00 10-K · filed 2022-04-15 | $0.00 derived: sum of 2 quarters · filed 2022-11-18 | $50.00K derived: sum of 3 quarters · filed 2022-11-18 | $100.00K 10-K · filed 2022-04-15 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-18 | $50.00K derived: sum of 2 quarters · filed 2022-11-18 | $100.00K 10-Q · filed 2022-11-18 | |
| 2021-06-30 | $50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22 | $100.00K 10-Q · filed 2022-08-22 | ||
| 2021-03-31 | $50.00K 10-Q · filed 2022-05-23 |